ARCHIVES

NCI says SELECT study is close to full enrollment.

This article is from The Cancer Letter archive.

Vol. 30 No. 17 | April 23, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI

May 19, 1989

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

In Brief: Simone Named New Director At St. Jude; Schein To Leave Georgetown For Job At Smith-Kline

September 16, 1983

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials

January 8, 1988